GleamWall
中文EN

PGNY Progyny, Inc.

Services-Misc Health & Allied Services, NEC · Nasdaq · SEC CIK 1551306 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.5%
TTM net income YoY60.9%
TTM EPS YoY73.0%
Revenue 3-yr CAGR9.0%
Net income 3-yr CAGR20.5%

Margins

Gross margin24.9%
Operating margin9.4%
Net margin6.8%
FCF margin13.4%
EBITDA margin9.9%

Returns

ROE18.7%
ROA12.4%
ROIC (approx.)23.9%
Asset turnover1.82x

Leverage & solvency

Liabilities / assets38.7%
Debt / equity0.00x
Current ratio1.93x
Interest coverage—

Cash quality & payout

Operating cash flow / net income2.28x
Accruals ratio-15.8%
Payout ratio—
Capex / revenue2.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$1.29B$1.17B$1.09B$786.91M$500.62M
Cost of revenue$984.18M$913.86M$849.80M$619.59M$388.49M
Gross profit$304.48M$253.36M$238.80M$167.32M$112.14M
R&D expense$9.50M————
SG&A expense$147.09M$121.96M$117.13M$98.33M$59.62M
Operating income$85.28M$67.45M$62.18M$23.34M$32.34M
Pretax income$95.43M$83.20M$70.69M$24.44M$32.44M
Income tax$36.91M$28.87M$8.65M-$5.92M-$33.33M
Net income$58.52M$54.34M$62.04M$30.36M$65.77M
EBITDA$90.22M$70.63M$64.47M$24.94M$33.64M
EPS (basic)0.680.590.650.330.74
EPS (diluted)0.650.570.620.300.66
Weighted avg. shares (diluted)89.86M95.45M100.67M99.96M100.36M
Banking
Net interest income——$3.30M$814,000$461,000
Balance sheet
Cash & equivalents$112.24M$162.31M$97.30M$120.08M$91.41M
Short-term investments$197.86M$65.64M$273.79M$69.22M$28.00M
Receivables$220.29M$235.32M$241.87M$240.07M$134.56M
Current assets$551.77M$472.72M$640.41M$433.86M$258.54M
PP&E, net$29.93M$12.38M$10.21M$8.37M$5.03M
Goodwill$19.98M$15.53M$11.88M$11.88M$11.88M
Intangibles$6.22M$1.30M$0$99,000$599,000
Total assets$742.43M$607.10M$756.62M$542.99M$358.06M
Current liabilities$202.39M$168.63M$185.95M$159.54M$98.82M
Total liabilities$226.39M$185.04M$203.19M$166.02M$106.24M
Shareholders' equity$516.04M$422.06M$553.43M$376.97M$251.82M
Shares outstanding83.37M85.31M96.35M93.30M91.09M
Cash flow statement
Operating cash flow$210.19M$179.10M$188.81M$80.39M$26.04M
Capital expenditure$18.41M$5.41M$3.64M$3.24M$2.13M
Free cash flow$191.78M$173.70M$185.17M$77.15M$23.91M
Investing cash flow-$159.01M$195.79M-$200.53M-$43.87M$8.77M
Financing cash flow-$99.36M-$309.88M-$11.07M-$7.86M-$13.70M
Depreciation & amortization$4.95M$3.17M$2.28M$1.60M$1.30M
Stock-based compensation$131.87M$128.13M$122.61M$100.75M$33.71M
Share buybacks$81.66M$300.28M$0$0—

Free plan shows the latest 5 periods; Pro shows all 9 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-19 06:28.